Navigation Links
Autism Spectrum Disorders Market Analysis & 2022 Forecasts in New Research Report at RnRMarketResearch.com
Date:10/22/2013

Dallas, TX (PRWEB) October 22, 2013

Autism Spectrum Disorders (ASD) is a group of incurable, developmental disabilities which affect the brain and are usually diagnosed between the ages of 18–24 months. ASD encompasses a broad spectrum of disorders in which the severity of the condition, the nature of impairment, the social and communication skills, time of onset of the condition, and the way the brain perceives information, vary among the affected individuals.

Complete report is available @ http://www.rnrmarketresearch.com/epicast-report-autism-spectrum-disorders-epidemiology-forecast-to-2022-market-report.html.

Epidemiological literature suggests an increase in the diagnosed prevalence of ASD over time. However, it remains unclear whether the increase in the diagnosed prevalence is due to a true increase in the prevalence of ASD, or due to an increase in the diagnosis of ASD because of an increased availability and utilization of health services.

In 2012, there were 1,826,542 diagnosed prevalent cases of ASD in the 6MM, with approximately 90% of the diagnosed prevalent cases (1,630,499 prevalent cases) in the US alone. GlobalData epidemiologists forecast that there will be 1,952,647 diagnosed prevalent cases of ASD in the 6MM by 2022, with an overall annual growth rate (AGR) of 0.69% during the forecast period.

Better surveillance techniques and the creation of centralized ASD registries in all countries could provide robust and reliable data for determining the true burden of the condition. Evidence generated through additional research could be further utilized to formulate policies to control for the risk factors associated with ASD, and possibly reduce the incidence of ASD in the future.

Scope

  •     The Autism Spectrum Disorders EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of autism spectrum disorders in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast (2012–2022) of the prevalent cases of autism spectrum disorders segmented by age (in five-year increments beginning at age 0 and ending at age 19 years) and sex in the 6MM.
  •     The autism spectrum disorders epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
  •     The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.
  •     The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons To Buy

  •     Develop business strategies by understanding the trends shaping and driving the global autism spectrum disorders market.
  •     Quantify patient populations in the global autism spectrum disorders market to improve product design, pricing, and launch plans.
  •     Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for autism spectrum disorders therapeutics in each of the markets covered.
  •     Identify the percentage of prevalent cases with different subtypes of autism spectrum disorders.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=121289.

Browse more reports on Neurology therapeutics Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-therapeutics.

Contact sales(at)rnrmarketresearch(dot)com for further information.

About Us:
RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/autism-spectrum-disorders/industry-2022-forecast/prweb11255386.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Autism Speaks Gets New Support Starting This October
2. Autism Research Group to Host “Teaching Perspective Taking to Individuals with Autism” Workshop on Nov. 6, in Westlake Village
3. Findings: How viral infection disrupts neural development in offspring, increasing risk of autism
4. UC Davis Researchers Find How Viral Infection Disrupts Neural Development in Offspring, Increasing Risk of Autism
5. Study Finds That a Subset of Children Often Considered to Have Autism May Be Misdiagnosed
6. New “Autism Live” Parent 2 Parent Online Videos Provide Unique Opportunity to Share, Learn and Grow
7. Young adults on the autism spectrum face tough prospects for jobs and independent living
8. Center for Autism and Related Disorders Helps New York Families Struggling with Autism Insurance Woes with No Cost Seminar, September 26
9. Who Killed Alex Spourdalakis? CBS and Autism Media Channel Present a Prelude to Tragedy
10. Researchers Discover a Potential Cause of Autism
11. Researchers from Mount Sinai receive NIH grant to study promising treatment for Autism subtype
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in Philadelphia ... announced an agreement to create the Jane and Leonard Korman Respiratory Institute in ... Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization and ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation ... Leadership in Neurology Award (PLINA). The couple joins a prestigious list of past ... Walter Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. ...
(Date:4/27/2017)... ... , ... Offering the purest product of its kind, Swissx Labs AG has ... than the market has seen before. Swissx uses proprietary strains of hemp plants grown ... process for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. ...
(Date:4/26/2017)... ... April 26, 2017 , ... Intalere, the healthcare ... podcast, “Make Plans for MACRA,” highlighting the impact of the Medicare ... and how physicians and other clinicians are reimbursed for the care they deliver ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... Datos ... a new partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider ... to link care plan incentives to a patient’s remote health progress, empowering the patient ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology: